Gene Therapy in Glioblastoma: From Vector Engineering to Immune Microenvironment Reprogramming
A narrative review comprehensively summarizes the advances achieved between 2016 and 2026 in GBM-directed gene therapy, focusing on the engineering principles, biological characteristics, and translational applications of viral vectors including retroviral, adenoviral, and adeno-associated viral systems.